Giuseppe Defazio

Mr. Giuseppe Defazio

University of Bari
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MMMarinella Marzano
Marinella Marzano
Bruno FossoBruno Fosso
Bruno Fosso
EPElisabetta Piancone
Elisabetta Piancone
Giuseppe DefazioGiuseppe Defazio
Giuseppe Defazio
Graziano PesoleGraziano Pesole
Graziano Pesole
MRMariangela De Robertis
Mariangela De Robertis
Colorectal cancer (CRC) initiation is believed to result from the conversion of normal intestinal stem cells (ISCs) into cancer stem cells (CSCs), also known as tumor-initiating cells (TICs). Hence, CRC evolves through the multiple acquisition of well-established genetic and epigenetic alterations with an adenoma-carcinoma sequence progression. Unlike other stem cells elsewhere in the body, ISCs cohabit with the intestinal microbiota, which consists of a diverse community of microorganisms, including bacteria, fungi, and viruses. The gut microbiota communicates closely with ISCs and mounting evidence suggests that there is significant crosstalk between host and microbiota at the ISC niche level. Metagenomic analyses have demonstrated that the host-microbiota mutually beneficial symbiosis existing under physiologic conditions is lost during a state of pathological microbial imbalance due to the alteration of microbiota composition (dysbiosis) and/or the genetic susceptibility of the host. The complex interaction between CRC and microbiota is at the forefront of the current CRC research, and there is growing attention on a possible role of the gut microbiome in the pathogenesis of CRC through ISC niche impairment. Here we primarily review the most recent findings on the molecular mechanism underlying the complex interplay between gut microbiota and ISCs, revealing a possible key role of microbiota in the aberrant reprogramming of CSCs in the initiation of CRC. We also discuss recent advances in OMICS approaches and single-cell analyses to explore the relationship between gut microbiota and ISC/CSC niche biology leading to a desirable implementation of the current precision medicine approaches.

7 June 2025 in Human Reproduction Open
Verified
Journal Article
Open access
ARAntoni Riera-Escamilla
Antoni Riera-Escamilla
MAMohamed M Arafa
Mohamed M Arafa
GFGinevra Farnetani
Ginevra Farnetani
MXMiguel J Xavier
Miguel J Xavier
MOManon S Oud
Manon S Oud
CKCsilla Krausz
Csilla Krausz
STUDY QUESTION: What is the diagnostic yield and the pre-testicular sperm extraction (TESE) prognostic value of a non-obstructive azoospermia (NOA)-specific virtual gene panel? SUMMARY ANSWER: The diagnostic yield in our cohort was 6.1%, and by combining our data with published literature, we identified 11 genes compatible with testicular sperm production and 19 genes associated with no sperm retrieval in carriers of pathogenic (P) or likely pathogenic (LP) mutations. WHAT IS KNOWN ALREADY: Azoospermia, the most severe form of male infertility, affects ∼1% of the male population, with TESE being the primary treatment option. However, in NOA, TESE fails in nearly 50% of cases and existing clinical parameters are unable to predict TESE failure. Over the past decade, next-generation sequencing (NGS) has identified several candidate NOA genes, but their diagnostic utility and impact on TESE outcomes have not been fully explored. STUDY DESIGN, SIZE AND DURATION: A literature search was addressed to identify well-established NOA genes for designing a specific virtual gene panel for NOA. Our retrospective study analysed the diagnostic yield of the NGS-based virtual gene panel, comprising 145 genes, in 571 men affected by idiopathic NOA with known TESE outcomes. Subsequently, a second literature search was performed to identify carriers of LP/P variants in the genes where we identified mutations, focusing on individuals with known TESE outcomes. This approach allowed us to integrate the published data with our findings and predict a genotype–phenotype correlation between the affected genes and TESE success. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: 571 NOA patients with known TESE outcomes were recruited in two European and one Middle East centres. Variants were obtained from a whole-exome sequencing dataset and crossed with the 145 genes of the virtual gene panel. After a filtering process, variants were manually assessed and classified according to ACMG guidelines by using two methods: (i) In order to compare our data with previously published studies, we applied ACMG-AMP guidelines along with ClinGen recommendations used by other similar studies. (ii) A new approach was used to optimize ACMG-AMP guidelines with all ClinGen recommendations and incorporated NOA-specific rules addressing phenotypic, locus, and allelic heterogeneity. LP and P variants were confirmed by Sanger sequencing. MAIN RESULTS AND THE ROLE OF CHANCE: By using the new variant classification approach adapted for NOA, we identified LP/P variants in 6.1% of patients, with a higher yield (9.4%) in cases with negative TESE outcomes and maturation arrest (11.7%). By integrating our findings with the literature, we highlight 19 genes recurrently associated with negative TESE outcomes and 11 genes associated with positive sperm retrieval either in the testis or in semen. TESE is recommended for patients with LP or P variants in the 11 specific genes. Notably, six of these genes are located on the X chromosome, therefore, these variants will be obligatorily transmitted to daughters, and potentially increase the risk of NOA-related infertility in male offspring. We observed that nine genes, in which we identified LP/P variants, have been previously described in individuals with premature ovarian insufficiency (POI). Of these, eight were associated with negative TESE outcomes in men. Furthermore, we propose seven additional genes mutated in our cohort of NOA patients as novel POI candidates. These genes have not yet been considered as POI candidates, but they result in female infertility when knocked out in mouse models. LARGE SCALE DATA: LP/P variants have been submitted to ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/). LIMITATIONS, REASONS FOR CAUTION: NOA is genetically heterogeneous, and our panel excludes those genes which were reported only in a single subject or single family. Although this can limit the diagnostic yield in our study, it ensures that only genes with clear relationship with NOA have been analysed. While in our cohort TESE outcomes are known for all patients, this information is often not available for mutation carriers in the published studies. Consequently, the total number of patients with P variants in the same gene remains relatively low, limiting our final conclusions. However, even if the number of carriers of genes associated with positive sperm retrieval is relatively low, it does not constrain our conclusions regarding TESE prediction. On the other hand, caution is warranted for genes linked to negative TESE outcomes, except for TEX11, SYCE1, and MSH4, each of which have 10 or more reported TESE-negative cases. WIDER IMPLICATIONS OF THE FINDINGS: Our study was performed on the largest available NOA cohort with known TESE outcomes. It not only provides an estimate on the diagnostic potential of a NOA-specific virtual gene panel, but it also advances the understanding of genetic factors influencing TESE outcomes. Half of the genes mutated in our study and presenting TESE-positive outcomes are already informative for clinical decision-making. The observed genotype–phenotype correlations may help in personalized decision-making prior to TESE, in order to undergo the procedure or to avoid unnecessary invasive treatment. It provides valuable insights that can inform clinical management strategies and potentially offer personalized treatments based on genetic profiles. The use of two different variant classification methods highlights that previous studies may have over-estimated the diagnostic yield, underscoring the need for a standardized variant classification approach addressed specifically to male infertility. Our study also emphasizes the overlap between NOA- and POI-associated genes, which has important clinical implications for genetic counselling of female siblings of affected individuals. STUDY FUNDING/COMPETING INTEREST(S): This work was funded by the Spanish Ministry of...

2 April 2026 in BioData Mining
Verified
Journal Article
Open access
PDF file
Giuseppe DefazioGiuseppe Defazio
Giuseppe Defazio
ELErika Lorusso
Erika Lorusso
MRMariangela De Robertis
Mariangela De Robertis
TMTommaso Mello
Tommaso Mello
AGAndrea Galli
Andrea Galli
Bruno FossoBruno Fosso
Bruno Fosso
The human gut microbiome plays a critical role in maintaining host health and homeostasis, and current literature suggests a bidirectional relationship bet

22 November 2024 in Briefings in Bioinformatics
Verified
Journal Article
Open access
Giuseppe DefazioGiuseppe Defazio
Giuseppe Defazio
MTMarco Antonio Tangaro
Marco Antonio Tangaro
Graziano PesoleGraziano Pesole
Graziano Pesole
Bruno FossoBruno Fosso
Bruno Fosso
The advent of high-throughput sequencing (HTS) technologies unlocked the complexity of the microbial world through the development of metagenomics, which now provides an unprecedented and comprehensive overview of its taxonomic and functional contribution in a huge variety of macro- and micro-ecosystems. In particular, shotgun metagenomics allows the reconstruction of microbial genomes, through the assembly of reads into MAGs (metagenome-assembled genomes). In fact, MAGs represent an information-rich proxy for inferring the taxonomic composition and the functional contribution of microbiomes, even if the relevant analytical approaches are not trivial and still improvable. In this regard, tools like CAMITAX and GTDBtk have implemented complex approaches, relying on marker gene identification and sequence alignments, requiring a large processing time. With the aim of deploying an effective tool for fast and reliable MAG taxonomic classification, we present here kMetaShot, a taxonomy classifier based on k-mer/minimizer counting. We benchmarked kMetaShot against CAMITAX and GTDBtk by using both in silico and real mock communities and demonstrated how, while implementing a fast and concise algorithm, it outperforms the other tools in terms of classification accuracy. Additionally, kMetaShot is an easy-to-install and easy-to-use bioinformatic tool that is also suitable for researchers with few command-line skills. It is available and documented at https://github.com/gdefazio/kMetaShot.

22 April 2025 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
DNDario Norello
Dario Norello
Giuseppe DefazioGiuseppe Defazio
Giuseppe Defazio
GCGiovanni Corona
Giovanni Corona
CCChiara Caiulo
Chiara Caiulo
MMMario Maggi
Mario Maggi
APAlessandro Peri
Alessandro Peri

12 June 2021 in Bioinformatics
Verified
Journal Article
Open access
PDF file
MTMarco A Tangaro
Marco A Tangaro
Giuseppe DefazioGiuseppe Defazio
Giuseppe Defazio
Bruno FossoBruno Fosso
Bruno Fosso
Flavio LicciulliFlavio Licciulli
Flavio Licciulli
GGGiorgio Grillo
Giorgio Grillo
MSMonica SANTAMARIA
Monica SANTAMARIA
ITSoneWB (ITSone WorkBench) is a Galaxy-based bioinformatic environment where comprehensive and high-quality reference data are connected with established pipelines and new tools in an automated and easy-to-use service targeted at global taxonomic analysis of eukaryotic communities based on Internal Transcribed Spacer 1 variants high-throughput sequencing. ITSoneWB has been deployed on the INFN-Bari ReCaS cloud facility and is freely available on the web at http://itsonewb.cloud.ba.infn.it/galaxy. Supplementary data are available at Bioinformatics online.